| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | nuclear retinoic acid receptor binding | 4.25e-08 | 55 | 122 | 7 | GO:0042974 | |
| GeneOntologyMolecularFunction | ubiquitin-like ligase-substrate adaptor activity | 1.10e-05 | 82 | 122 | 6 | GO:1990756 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | PRAMEF7 PRAMEF12 PPARG PRAMEF8 PRAMEF1 PRAMEF13 BAZ2A PRAMEF14 | 1.97e-05 | 187 | 122 | 8 | GO:0016922 |
| GeneOntologyMolecularFunction | enzyme-substrate adaptor activity | 2.56e-05 | 95 | 122 | 6 | GO:0140767 | |
| GeneOntologyMolecularFunction | RNA polymerase II sequence-specific DNA-binding transcription factor recruiting activity | 2.20e-04 | 4 | 122 | 2 | GO:0001010 | |
| GeneOntologyMolecularFunction | NADPH oxidase H202-forming activity | 3.66e-04 | 5 | 122 | 2 | GO:0106294 | |
| GeneOntologyMolecularFunction | kainate selective glutamate receptor activity | 5.47e-04 | 6 | 122 | 2 | GO:0015277 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 6.44e-04 | 171 | 122 | 6 | GO:0015081 | |
| GeneOntologyMolecularFunction | extracellularly glutamate-gated ion channel activity | 7.62e-04 | 7 | 122 | 2 | GO:0005234 | |
| GeneOntologyMolecularFunction | lysine-acetylated histone binding | 8.01e-04 | 30 | 122 | 3 | GO:0070577 | |
| GeneOntologyMolecularFunction | acetylation-dependent protein binding | 8.83e-04 | 31 | 122 | 3 | GO:0140033 | |
| GeneOntologyMolecularFunction | coreceptor activity | 9.90e-04 | 72 | 122 | 4 | GO:0015026 | |
| GeneOntologyMolecularFunction | signal recognition particle binding | 1.01e-03 | 8 | 122 | 2 | GO:0005047 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | PRAMEF7 PRAMEF12 STING1 PPARG PRAMEF8 PRAMEF1 PRAMEF13 BAZ2A PRAMEF14 | 1.06e-03 | 417 | 122 | 9 | GO:0061629 |
| GeneOntologyMolecularFunction | xenobiotic transmembrane transporter activity | 1.16e-03 | 34 | 122 | 3 | GO:0042910 | |
| GeneOntologyBiologicalProcess | somatic stem cell population maintenance | PRAMEF7 NANOGP8 NANOG PRAMEF12 PRAMEF8 PRAMEF1 PRAMEF13 PRAMEF14 | 2.55e-07 | 108 | 122 | 8 | GO:0035019 |
| GeneOntologyBiologicalProcess | blastocyst formation | 6.86e-06 | 78 | 122 | 6 | GO:0001825 | |
| GeneOntologyBiologicalProcess | negative regulation of cell differentiation | MYCN PRAMEF7 RC3H2 LILRB3 NANOGP8 NANOG DAB1 PRAMEF12 PPARG DCC PRAMEF8 PRAMEF1 ITGAV PRAMEF13 JAK3 HOXB8 PRAMEF14 | 1.56e-05 | 875 | 122 | 17 | GO:0045596 |
| GeneOntologyBiologicalProcess | oocyte development | 2.71e-05 | 99 | 122 | 6 | GO:0048599 | |
| GeneOntologyBiologicalProcess | oocyte differentiation | 3.39e-05 | 103 | 122 | 6 | GO:0009994 | |
| GeneOntologyBiologicalProcess | stem cell population maintenance | PRAMEF7 NANOGP8 NANOG PRAMEF12 PRAMEF8 PRAMEF1 PRAMEF13 PRAMEF14 | 8.44e-05 | 237 | 122 | 8 | GO:0019827 |
| GeneOntologyBiologicalProcess | blastocyst development | 9.54e-05 | 179 | 122 | 7 | GO:0001824 | |
| GeneOntologyBiologicalProcess | maintenance of cell number | PRAMEF7 NANOGP8 NANOG PRAMEF12 PRAMEF8 PRAMEF1 PRAMEF13 PRAMEF14 | 9.76e-05 | 242 | 122 | 8 | GO:0098727 |
| GeneOntologyBiologicalProcess | negative regulation of developmental process | MYCN PRAMEF7 RC3H2 LILRB3 CLSTN3 NANOGP8 NANOG DAB1 PRAMEF12 PPARG DCC PRAMEF8 PRAMEF1 ITGAV PRAMEF13 JAK3 HOXB8 PRAMEF14 MDGA1 | 9.84e-05 | 1220 | 122 | 19 | GO:0051093 |
| GeneOntologyCellularComponent | Cul2-RING ubiquitin ligase complex | 3.24e-07 | 47 | 123 | 6 | GO:0031462 | |
| MousePheno | abnormal spermatogonia proliferation | 7.20e-07 | 47 | 95 | 6 | MP:0002685 | |
| MousePheno | abnormal jejunum morphology | 8.05e-06 | 41 | 95 | 5 | MP:0004002 | |
| MousePheno | increased circulating amylase level | 1.61e-05 | 119 | 95 | 7 | MP:0008806 | |
| MousePheno | abnormal cecum morphology | 5.66e-05 | 99 | 95 | 6 | MP:0000494 | |
| MousePheno | increased kidney weight | 5.77e-05 | 145 | 95 | 7 | MP:0003917 | |
| MousePheno | abnormal duodenum morphology | 7.24e-05 | 64 | 95 | 5 | MP:0003271 | |
| MousePheno | abnormal circulating amylase level | 9.15e-05 | 156 | 95 | 7 | MP:0008804 | |
| MousePheno | abnormal large intestine morphology | MYCN PRAMEF7 PRAMEF12 PRAMEF8 PRAMEF1 PRAMEF13 ARAF JAK3 SCMH1 | 1.07e-04 | 276 | 95 | 9 | MP:0000489 |
| MousePheno | enlarged urinary bladder | 1.37e-04 | 116 | 95 | 6 | MP:0011874 | |
| Domain | PRAME_family | 1.18e-07 | 19 | 122 | 5 | IPR026271 | |
| Domain | DER1 | 1.26e-04 | 3 | 122 | 2 | IPR007599 | |
| Domain | TECPR | 1.26e-04 | 3 | 122 | 2 | SM00706 | |
| Domain | Beta-propeller_rpt_TECPR | 1.26e-04 | 3 | 122 | 2 | IPR006624 | |
| Pubmed | PRAMEF7 NANOGP8 NANOG PRAMEF12 PRAMEF8 PRAMEF1 PRAMEF13 PRAMEF14 | 5.51e-12 | 46 | 126 | 8 | 17287250 | |
| Pubmed | Thirteen Ovary-Enriched Genes Are Individually Not Essential for Female Fertility in Mice. | 1.31e-11 | 30 | 126 | 7 | 38786026 | |
| Pubmed | 3.59e-11 | 18 | 126 | 6 | 23894331 | ||
| Pubmed | Oogenesin is a novel mouse protein expressed in oocytes and early cleavage-stage embryos. | 3.59e-11 | 18 | 126 | 6 | 12890732 | |
| Pubmed | Oocyte-specific gene Oog1 suppresses the expression of spermatogenesis-specific genes in oocytes. | 3.59e-11 | 18 | 126 | 6 | 29731491 | |
| Pubmed | 3.59e-11 | 18 | 126 | 6 | 14675769 | ||
| Pubmed | Pramel7 mediates ground-state pluripotency through proteasomal-epigenetic combined pathways. | 5.23e-11 | 19 | 126 | 6 | 28604677 | |
| Pubmed | 7.45e-11 | 20 | 126 | 6 | 26694250 | ||
| Pubmed | 7.45e-11 | 20 | 126 | 6 | 16580637 | ||
| Pubmed | Pramel7 mediates LIF/STAT3-dependent self-renewal in embryonic stem cells. | 7.45e-11 | 20 | 126 | 6 | 21425410 | |
| Pubmed | 1.43e-10 | 22 | 126 | 6 | 31729367 | ||
| Pubmed | 1.92e-10 | 23 | 126 | 6 | 19480014 | ||
| Pubmed | Incomplete reactivation of Oct4-related genes in mouse embryos cloned from somatic nuclei. | 3.36e-10 | 25 | 126 | 6 | 12620990 | |
| Pubmed | 3.36e-10 | 25 | 126 | 6 | 37451217 | ||
| Pubmed | Expression profiling in transgenic FVB/N embryonic stem cells overexpressing STAT3. | 4.35e-10 | 26 | 126 | 6 | 18500982 | |
| Pubmed | 7.08e-10 | 28 | 126 | 6 | 25089626 | ||
| Pubmed | LSM14B is essential for oocyte meiotic maturation by regulating maternal mRNA storage and clearance. | 1.68e-09 | 32 | 126 | 6 | 37889087 | |
| Pubmed | 2.99e-09 | 35 | 126 | 6 | 19389355 | ||
| Pubmed | Differential expression of PRAMEL1, a cancer/testis antigen, during spermatogenesis in the mouse. | 3.44e-09 | 17 | 126 | 5 | 23565261 | |
| Pubmed | 3.44e-09 | 17 | 126 | 5 | 37781892 | ||
| Pubmed | Pramel15 facilitates zygotic nuclear DNMT1 degradation and DNA demethylation. | 4.75e-09 | 18 | 126 | 5 | 39181896 | |
| Pubmed | DUX is a non-essential synchronizer of zygotic genome activation. | 2.80e-08 | 50 | 126 | 6 | 31806660 | |
| Pubmed | 7.72e-08 | 59 | 126 | 6 | 11279525 | ||
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | PRAMEF7 ARHGAP10 MCAM PRAMEF12 PPARG DCC PRAMEF8 PRAMEF1 PRAMEF13 SCMH1 PRAMEF14 | 9.59e-08 | 363 | 126 | 11 | 14691545 |
| Pubmed | 9.21e-07 | 6 | 126 | 3 | 23085571 | ||
| Pubmed | 2.26e-06 | 58 | 126 | 5 | 31598710 | ||
| Pubmed | AMPK Promotes SPOP-Mediated NANOG Degradation to Regulate Prostate Cancer Cell Stemness. | 3.84e-06 | 9 | 126 | 3 | 30595535 | |
| Pubmed | Genetic Complexity of Crohn's Disease in Two Large Ashkenazi Jewish Families. | 1.30e-05 | 2 | 126 | 2 | 27373512 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 15673679 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 37735940 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 11182092 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 14724198 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 15539395 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 7696618 | ||
| Pubmed | Expression and novel subunit isoforms of glutamate receptor genes GluR5 and GluR6. | 1.30e-05 | 2 | 126 | 2 | 8260617 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 18826608 | ||
| Pubmed | Functional evidence that the self-renewal gene NANOG regulates human tumor development. | 1.30e-05 | 2 | 126 | 2 | 19415763 | |
| Pubmed | Assessing the role of GLUK5 and GLUK6 at hippocampal mossy fiber synapses. | 1.30e-05 | 2 | 126 | 2 | 15537878 | |
| Pubmed | Characterization of LILRB3 and LILRA6 allelic variants in the Japanese population. | 1.30e-05 | 2 | 126 | 2 | 33526815 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 15358807 | ||
| Pubmed | Role of GluK1 kainate receptors in seizures, epileptic discharges, and epileptogenesis. | 1.30e-05 | 2 | 126 | 2 | 24760837 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 23555306 | ||
| Pubmed | ER-lysosome lipid transfer protein VPS13C/PARK23 prevents aberrant mtDNA-dependent STING signaling. | 1.30e-05 | 2 | 126 | 2 | 35657605 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 11069933 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 12947409 | ||
| Pubmed | Distinct frequency patterns of LILRB3 and LILRA6 allelic variants in Europeans. | 1.30e-05 | 2 | 126 | 2 | 36449053 | |
| Pubmed | Kainate receptor-mediated synaptic transmission in the adult anterior cingulate cortex. | 1.30e-05 | 2 | 126 | 2 | 15928066 | |
| Pubmed | Q/R site editing in kainate receptor GluR5 and GluR6 pre-mRNAs requires distant intronic sequences. | 1.30e-05 | 2 | 126 | 2 | 8700852 | |
| Pubmed | Q/R site editing controls kainate receptor inhibition by membrane fatty acids. | 1.30e-05 | 2 | 126 | 2 | 16221857 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 16219388 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 34083514 | ||
| Pubmed | Subunit composition and alternative splicing regulate membrane delivery of kainate receptors. | 1.30e-05 | 2 | 126 | 2 | 15014126 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 19617579 | ||
| Pubmed | Subunit composition of kainate receptors in hippocampal interneurons. | 1.30e-05 | 2 | 126 | 2 | 11144357 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 24598770 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 25043179 | ||
| Pubmed | Differential expression of nanog1 and nanogp8 in colon cancer cells. | 1.30e-05 | 2 | 126 | 2 | 22079639 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 29590626 | ||
| Pubmed | MCAM knockdown impairs PPARγ expression and 3T3-L1 fibroblasts differentiation to adipocytes. | 1.30e-05 | 2 | 126 | 2 | 29468504 | |
| Pubmed | A mosaic of functional kainate receptors in hippocampal interneurons. | 1.30e-05 | 2 | 126 | 2 | 15483117 | |
| Pubmed | Functional characterization of kainate receptors in the mouse nucleus accumbens. | 1.30e-05 | 2 | 126 | 2 | 11985817 | |
| Pubmed | Diversity of the human LILRB3/A6 locus encoding a myeloid inhibitory and activating receptor pair. | 1.30e-05 | 2 | 126 | 2 | 24096970 | |
| Pubmed | Expression of NANOG and NANOGP8 in a variety of undifferentiated and differentiated human cells. | 1.30e-05 | 2 | 126 | 2 | 21136380 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 39306342 | ||
| Pubmed | 2.09e-05 | 91 | 126 | 5 | 22610502 | ||
| Pubmed | PRAMEF7 PRAMEF12 PRAMEF8 PRAMEF1 PRAMEF13 TCL1B PER3 PRAMEF14 | 2.63e-05 | 326 | 126 | 8 | 17015433 | |
| Pubmed | The pluripotency factor NANOG controls primitive hematopoiesis and directly regulates Tal1. | 3.90e-05 | 3 | 126 | 2 | 30814124 | |
| Pubmed | Multiple phases in regulation of Nanog expression during pre-implantation development. | 3.90e-05 | 3 | 126 | 2 | 26660234 | |
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 33727640 | ||
| Pubmed | Crystal structure and DNA binding of the homeodomain of the stem cell transcription factor Nanog. | 3.90e-05 | 3 | 126 | 2 | 18177668 | |
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 24929238 | ||
| Pubmed | Nanog and transcriptional networks in embryonic stem cell pluripotency. | 3.90e-05 | 3 | 126 | 2 | 17211451 | |
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 15502159 | ||
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 20574542 | ||
| Pubmed | lincRNAs act in the circuitry controlling pluripotency and differentiation. | 3.90e-05 | 3 | 126 | 2 | 21874018 | |
| Pubmed | Cell signalling regulates dynamics of Nanog distribution in embryonic stem cell populations. | 3.90e-05 | 3 | 126 | 2 | 23054952 | |
| Pubmed | CrxOS maintains the self-renewal capacity of murine embryonic stem cells. | 3.90e-05 | 3 | 126 | 2 | 19800316 | |
| Pubmed | Selenium Augments microRNA Directed Reprogramming of Fibroblasts to Cardiomyocytes via Nanog. | 3.90e-05 | 3 | 126 | 2 | 26975336 | |
| Pubmed | Nanog suppresses cell migration by downregulating thymosin β4 and Rnd3. | 3.90e-05 | 3 | 126 | 2 | 23329853 | |
| Pubmed | Distinct Subunit Domains Govern Synaptic Stability and Specificity of the Kainate Receptor. | 3.90e-05 | 3 | 126 | 2 | 27346345 | |
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 1379666 | ||
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 8730589 | ||
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 23665121 | ||
| Pubmed | Ectopic overexpression of Nanog induces tumorigenesis in non-tumorous fibroblasts. | 3.90e-05 | 3 | 126 | 2 | 26733157 | |
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 16501172 | ||
| Pubmed | Regulated fluctuations in nanog expression mediate cell fate decisions in embryonic stem cells. | 3.90e-05 | 3 | 126 | 2 | 19582141 | |
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 19703398 | ||
| Pubmed | Nanog Fluctuations in Embryonic Stem Cells Highlight the Problem of Measurement in Cell Biology. | 3.90e-05 | 3 | 126 | 2 | 28636920 | |
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 20539761 | ||
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 18584034 | ||
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 30143592 | ||
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 21969378 | ||
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 20661723 | ||
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 29245050 | ||
| Pubmed | Aggregation of embryonic stem cells induces Nanog repression and primitive endoderm differentiation. | 3.90e-05 | 3 | 126 | 2 | 15494369 | |
| Pubmed | Identification of two distinct transactivation domains in the pluripotency sustaining factor nanog. | 3.90e-05 | 3 | 126 | 2 | 14728807 | |
| Pubmed | Nanog overcomes reprogramming barriers and induces pluripotency in minimal conditions. | 3.90e-05 | 3 | 126 | 2 | 21194951 | |
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 22388986 | ||
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 16791199 | ||
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 31513786 | ||
| Interaction | PTK2B interactions | 6.43e-06 | 119 | 118 | 7 | int:PTK2B | |
| Cytoband | 1p36.21 | 2.27e-08 | 63 | 126 | 6 | 1p36.21 | |
| Cytoband | 19q13.4 | 6.93e-05 | 79 | 126 | 4 | 19q13.4 | |
| Cytoband | 17q21.33 | 1.99e-04 | 41 | 126 | 3 | 17q21.33 | |
| Cytoband | 7p22.1 | 3.00e-04 | 47 | 126 | 3 | 7p22.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p36 | PRAMEF7 PRAMEF12 HES3 PRAMEF8 PRAMEF1 PRAMEF13 PER3 PRAMEF14 | 6.10e-04 | 681 | 126 | 8 | chr1p36 |
| GeneFamily | PRAME family | 1.22e-09 | 24 | 86 | 6 | 686 | |
| GeneFamily | Glutamate ionotropic receptor kainate type subunits | 2.22e-04 | 5 | 86 | 2 | 1199 | |
| GeneFamily | Solute carriers | SLC47A2 SLC9A4 SLC13A4 SLC16A5 SLC38A7 SLC29A4 SLC35B1 SLC23A3 | 5.81e-04 | 395 | 86 | 8 | 752 |
| GeneFamily | Dolichyl D-mannosyl phosphate dependent mannosyltransferases|Phosphatidylinositol glycan anchor biosynthesis | 7.88e-04 | 9 | 86 | 2 | 430 | |
| GeneFamily | Rhomboid family | 1.96e-03 | 14 | 86 | 2 | 926 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 2.72e-03 | 394 | 86 | 7 | 471 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED | 2.96e-07 | 57 | 124 | 6 | MM1262 | |
| Coexpression | KINNEY_DNMT1_METHYLATION_TARGETS | 5.45e-07 | 34 | 124 | 5 | MM955 | |
| Coexpression | KOHOUTEK_CCNT2_TARGETS | 2.41e-06 | 81 | 124 | 6 | MM938 | |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED | MYCN PRAMEF7 LDHAL6B PRAMEF12 PRAMEF8 PRAMEF1 PRAMEF13 JAK3 PLCE1 | 4.39e-06 | 261 | 124 | 9 | MM1277 |
| Coexpression | MORI_SMALL_PRE_BII_LYMPHOCYTE_UP | 7.32e-06 | 98 | 124 | 6 | MM592 | |
| Coexpression | HUANG_GATA2_TARGETS_DN | 7.32e-06 | 98 | 124 | 6 | MM942 | |
| Coexpression | INGRAM_SHH_TARGETS_UP | 9.72e-06 | 156 | 124 | 7 | MM550 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 9.99e-08 | 200 | 125 | 8 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 9.99e-08 | 200 | 125 | 8 | cc3409518f8b436ea92deb955e81114b3f410ff7 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | 9.99e-08 | 200 | 125 | 8 | c24a3099e3d96d8b72f6d05286bb355d661a0377 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 9.99e-08 | 200 | 125 | 8 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 9.99e-08 | 200 | 125 | 8 | 310cd53db1c137f6af74e6ae682221d7ac27310c | |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 9.99e-08 | 200 | 125 | 8 | 961858738ce35db8760c8c2e136f8369bc444ccf | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.46e-06 | 157 | 125 | 6 | 1f21d78a467fe22c5ab75d0917b840c1ac93f32c | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.39e-05 | 185 | 125 | 6 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.44e-05 | 186 | 125 | 6 | a95744b8649096bd7cfc3591a02841fa411085b3 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.72e-05 | 192 | 125 | 6 | 67d6230e32d446dcb12047fae2c3f1faa80dd720 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.10e-05 | 199 | 125 | 6 | 121de4e02585de3a3010398387c523bacf8ce546 | |
| ToppCell | MS-IIF-Lymphocyte-B-B_naive|IIF / Disease, condition lineage and cell class | 2.16e-05 | 200 | 125 | 6 | 15f429137b2a3906724118085fcd59750cd767c7 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.16e-05 | 200 | 125 | 6 | 107854f4855fc99c9f7e737eb246f0d868e6c5fd | |
| Disease | mood instability measurement | 1.43e-04 | 128 | 114 | 5 | EFO_0008475 | |
| Disease | NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE | 2.11e-04 | 30 | 114 | 3 | C1868672 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily B member 3 measurement | 2.20e-04 | 6 | 114 | 2 | EFO_0802705 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily A member 6 measurement | 2.20e-04 | 6 | 114 | 2 | EFO_0801767 | |
| Disease | interleukin 18 receptor accessory protein measurement | 5.23e-04 | 9 | 114 | 2 | EFO_0008179 | |
| Disease | HIV-1 infection | 5.77e-04 | 98 | 114 | 4 | EFO_0000180 | |
| Disease | Schizophrenia | HTR4 CP GRIK1 GRIK2 DCC CSF2RB STON2 CSMD1 MDGA1 TNXB SLC23A3 | 6.34e-04 | 883 | 114 | 11 | C0036341 |
| Disease | leprosy | 6.96e-04 | 103 | 114 | 4 | EFO_0001054 | |
| Disease | colon cancer (implicated_via_orthology) | 7.95e-04 | 11 | 114 | 2 | DOID:219 (implicated_via_orthology) | |
| Disease | esophageal squamous cell carcinoma | 1.12e-03 | 13 | 114 | 2 | EFO_0005922 | |
| Disease | glycodeoxycholate measurement | 1.31e-03 | 14 | 114 | 2 | EFO_0010493 | |
| Disease | Psoriasis | 1.41e-03 | 57 | 114 | 3 | C0033860 | |
| Disease | Pustulosis of Palms and Soles | 1.41e-03 | 57 | 114 | 3 | C0030246 | |
| Disease | tuberculosis | 1.54e-03 | 216 | 114 | 5 | MONDO_0018076 | |
| Disease | response to vaccine, cytokine measurement | 1.70e-03 | 131 | 114 | 4 | EFO_0004645, EFO_0004873 | |
| Disease | amygdala volume change measurement | 1.71e-03 | 16 | 114 | 2 | EFO_0021490 | |
| Disease | cataract | 2.22e-03 | 141 | 114 | 4 | MONDO_0005129 | |
| Disease | lung cancer | 2.96e-03 | 21 | 114 | 2 | MONDO_0008903 | |
| Disease | glaucoma | 3.05e-03 | 154 | 114 | 4 | MONDO_0005041 | |
| Disease | triacylglycerol 58:9 measurement | 3.25e-03 | 22 | 114 | 2 | EFO_0010443 | |
| Disease | Autistic Disorder | 3.50e-03 | 261 | 114 | 5 | C0004352 | |
| Disease | feeling miserable measurement | 3.59e-03 | 79 | 114 | 3 | EFO_0009598 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QSFPWGKIPLNALTM | 326 | Q9BXU7 | |
| APNPDWASLNLGALM | 646 | Q96P47 | |
| VDLLPMPGPNANWTA | 316 | Q9BQT9 | |
| GTEAPSIWLTGMNLP | 266 | Q96PZ7 | |
| SIWLTGMNLPSPVIS | 271 | Q96PZ7 | |
| GMNLPSPVISSKNWL | 276 | Q96PZ7 | |
| DQPPILTTNTGLQMW | 1471 | Q6UVK1 | |
| QPLLMTSWNIPTAEG | 1876 | Q8IZF6 | |
| SPDPQALWFNISAQM | 1316 | Q9UIF9 | |
| PRQLPAFQEGIMSWS | 1491 | Q9UIF9 | |
| GVFSFLNPLSPDIWM | 566 | P39086 | |
| WPPTLLQMVHTLASN | 56 | Q9Y2X7 | |
| SLLPMPLLSQAQWNE | 11 | B6SEH9 | |
| LLTFQAPFLPWALMG | 146 | Q96Q80 | |
| MQLFGPWGEIVSPSL | 1301 | Q76LX8 | |
| MPVQAAQWTEFLSCP | 1 | Q9HBD1 | |
| LLPQFRAPSWQTGMH | 21 | Q2KHR3 | |
| PSFSALGPQLDMLWS | 1086 | P52333 | |
| WSAPSNPLVIMVTGN | 106 | P43630 | |
| NLFPQTSLTLHMWPD | 676 | P00450 | |
| CQSSPQLWGPMAIFL | 936 | Q8NFP4 | |
| IPGQTRSSMVQWLNP | 676 | A1A4S6 | |
| MLILPLNNFPWVING | 546 | Q5T3U5 | |
| PQTNCIIMSWTPPLN | 736 | P43146 | |
| PAFAFRSVPWLMTLN | 66 | Q9HBL6 | |
| GNPWLQMPTIADRSA | 366 | Q96LI6 | |
| MQAFTGCVPLLPWLA | 641 | Q9UBB6 | |
| NNLPFTEPMLSVWAQ | 2271 | O95714 | |
| LNLTGMIPADAPAQW | 446 | Q5MY95 | |
| VPPSLAGIMQRTFAW | 126 | Q96FN5 | |
| FPRDSQNPLLMWAAP | 211 | Q9NRD8 | |
| SLLPMPLLSQAQWNE | 11 | B6SEH8 | |
| FCEPWTLNMQPAPLT | 651 | P56645 | |
| IPLNGTWLFTPVSKM | 36 | Q9BYZ2 | |
| MWPNITAAPFLLTGF | 1 | Q9Y5P1 | |
| TGSIPQMLYNLWGPD | 81 | Q8NHA6 | |
| DSLMQFGGATPWTPL | 386 | Q9BUK6 | |
| MRSLQNSLQGLWPVP | 46 | Q5TGS1 | |
| LVNPTGNLPMWSNQT | 186 | Q9H9S0 | |
| GWGLPVQSPQALVAM | 851 | Q8TDZ2 | |
| TWNGNFFPPQMTLLP | 151 | Q8N5I3 | |
| WSAPSDPLNILMAGQ | 306 | Q6PI73 | |
| WSAPSDPLNILMAGQ | 306 | O75022 | |
| TGMWNPNAPVFLALN | 366 | Q5R372 | |
| PTQLFPWMRPQAAAG | 131 | P17481 | |
| SAPPLLCQMTEGSWI | 766 | Q5K4E3 | |
| VQAWPFTCLPLGSLM | 56 | O95522 | |
| FQAMSQAVGLPPWLQ | 136 | Q96BN8 | |
| TLGNPTNVRNMSWLP | 491 | Q8N264 | |
| TDMLLSVPANPGISW | 151 | Q8N0W3 | |
| SVSSVLPCFMGWIPQ | 4241 | Q8NCM8 | |
| QPLEQPSGSVLWMAA | 461 | P10398 | |
| GPPFWQSMIPVLNIQ | 231 | Q9Y6K0 | |
| LFQNGSAELWPPGSM | 486 | P32927 | |
| STQGLFVAMFWPLIP | 401 | Q9NZS9 | |
| NMWGPTRLPTCVSVF | 136 | P20023 | |
| MGAVLPSFWGQQPLV | 336 | O75553 | |
| VPVMLSNGWELPFSE | 356 | Q16394 | |
| LLGPDWNCIPQMTTF | 546 | Q14CM0 | |
| MSFPLSDQPVLGEWF | 191 | Q8IZJ3 | |
| LVTTNVTWGIQPAPM | 976 | P06756 | |
| WASNPGMESLVPLVQ | 326 | Q49AR2 | |
| PPILGQTILTQWMMF | 496 | Q6UWU2 | |
| VSGFSPPNILLMWLE | 296 | P01880 | |
| WVIPTFISFLPIMQG | 146 | Q13639 | |
| SSNVPLPLLQGWVMF | 56 | Q969L2 | |
| LVGTFPWMAPEVIQS | 166 | Q9NYL2 | |
| NVAMPSWFDIIGLSP | 66 | O75608 | |
| AFNTPTGIPWAMVNL | 301 | O60476 | |
| QMPFSSLIGQTPRWH | 126 | Q6PJP8 | |
| LLNFQAPFLPWVLMG | 146 | Q9GZP9 | |
| GVFSFLNPLSPDIWM | 551 | Q13002 | |
| AWMLGASQLSVPPLD | 186 | O60269 | |
| VQAWPFTRLPLGSLM | 56 | Q5VWM4 | |
| NQMLSLSSLPPWAVT | 491 | Q9UKG4 | |
| TQAPSSGLEGLMPQW | 2111 | Q8TDX9 | |
| VQAWPFTCLPLGSLM | 56 | Q5VWM6 | |
| QLVNVAIFGPPWMAF | 421 | P43121 | |
| WSVPPFLLFLVSSGM | 201 | P59533 | |
| LWQVADLGSSLNMPP | 1021 | Q93008 | |
| NAVGPPFTWMLALLG | 111 | Q86WV6 | |
| RLFPMTPNWFLNLSA | 161 | Q96HV5 | |
| GVAAVITPWNFPSAM | 196 | P51649 | |
| LAQDPQSPMAGLRWL | 731 | Q9UKY4 | |
| QDWGPFFSLAVPSML | 286 | Q86VL8 | |
| AVPTPLPWNAMSLQI | 46 | Q8TF66 | |
| VQAWPFTCLPLGSLM | 56 | Q5SWL7 | |
| SSNPNPLMFWLHGIQ | 1796 | Q9P212 | |
| PVWTAPTFTHRQMLG | 651 | Q15572 | |
| LVNPTGNLPMWSNQT | 186 | Q6NSW7 | |
| MPFWPTNFGISSVDL | 36 | P37231 | |
| RSQPGMWPQSLSELV | 326 | Q86VE3 | |
| MPTRPFFENIGSILW | 146 | Q6AI14 | |
| PGNILTRPASWMAVF | 231 | Q9NVC3 | |
| AQVMQTIPPGLFWRF | 406 | Q9UKZ4 | |
| VQAWPFTCLPLGSLM | 56 | O95521 | |
| ALMWAKVNPFSPLGT | 1301 | Q8IZU2 | |
| DWQMAPGRGLPNLLT | 141 | Q8NHX4 | |
| PLSQTGLNWPEMITA | 846 | Q12769 | |
| ILFANPISPMQWVGT | 286 | P78383 | |
| QTWMGSRLPLVQAPS | 101 | Q6PIS1 | |
| QVALGSIWLMLPTPF | 871 | Q8WXE9 | |
| PLGFRLNASSWPMFL | 126 | Q96GD3 | |
| VQAWPFTRLPLGSLM | 56 | Q5VXH5 | |
| SPTPSNLPMVQLWAA | 96 | O15417 | |
| MSQAWVPGLAPTLLF | 1 | Q6UXU6 | |
| MWSVLGFPLPQVFLV | 246 | O15375 | |
| TPNPVILQDCMWSGF | 106 | P04198 | |
| PLSFLVNSWLPGMLD | 366 | Q9P2C4 | |
| MNVWLTPNLQPFVGG | 166 | Q8TB22 | |
| SWTPIAQNRGIMPFP | 116 | P15498 | |
| LQAMWGQSLLPPVST | 4001 | P22105 | |
| LLQQWGAEITMPAPS | 96 | Q9Y6I0 | |
| ILSFELPMNLANWFP | 1046 | Q9GZR1 | |
| WLQVDNQLPGAMFPV | 3206 | Q709C8 | |
| VGTQPLNPSLMLPAW | 1241 | O15040 | |
| GSLLVARTQPSPWQM | 381 | Q15904 | |
| SGQMPFSQLPAVWQL | 76 | O95988 | |
| PAWPCIFSLLMGISN | 446 | Q7RTT9 | |
| ALWSTYGAMIPTQLP | 36 | Q5VWN6 | |
| QVLQPDMLPAQWTAG | 406 | Q9BR11 | |
| SFMWPNSTPVPLLQT | 221 | Q14679 | |
| WLLNPLPMAVSSRGN | 131 | Q9H3S5 | |
| NASFMPGLWSPQEFI | 876 | Q9HD43 | |
| AMLALFSNPNPAEAW | 306 | Q68DK2 | |
| QLAAEPVPTGFFNMW | 356 | Q9HAD4 | |
| QPMITSIPLNLWGQD | 81 | P63124 | |
| AAIANWSELAPMPVG | 321 | Q96NJ5 | |
| LEPQQLMDFWSAPQG | 36 | Q86W25 | |
| WMPQNVPAESGAQLL | 971 | Q8IZF0 |